Education
About Us
Working with TipRanks
Follow Us
Inoviq Ltd (AU:IIQ)
ASX:IIQ
IIQ Stock Chart & Stats
AU$0.34
AU$0.02(3.09%)
At close: 4:00 PM EST
AU$0.34
AU$0.02(3.09%)
Day’s Range― - ―
52-Week RangeAU$0.34 - AU$0.69
Previous CloseN/A
Volume76.26K
Average Volume (3M)196.06K
Market Cap
AU$49.96M
Enterprise ValueAU$35.15M
Total Cash (Recent Filing)AU$6.52M
Total Debt (Recent Filing)AU$376.19K
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Feb 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding138,775,670
10 Day Avg. Volume262,451
30 Day Avg. Volume196,057
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)2.46
Price to Sales (P/S)22.67
P/FCF Ratio-8.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Sell
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Inoviq Ltd News
IIQ FAQ
What was Inoviq Ltd’s price range in the past 12 months?
Inoviq Ltd lowest share price was AU$0.34 and its highest was AU$0.69 in the past 12 months.
What is Inoviq Ltd’s market cap?
Inoviq Ltd’s market cap is AU$49.96M.
When is Inoviq Ltd’s upcoming earnings report date?
Inoviq Ltd’s upcoming earnings report date is Feb 20, 2026 which is in 92 days.
How were Inoviq Ltd’s earnings last quarter?
Inoviq Ltd released its earnings results on Aug 22, 2025. The company reported -AU$0.029 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.029.
Is Inoviq Ltd overvalued?
According to Wall Street analysts Inoviq Ltd’s price is currently Overvalued.
Does Inoviq Ltd pay dividends?
Inoviq Ltd does not currently pay dividends.
What is Inoviq Ltd’s EPS estimate?
Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inoviq Ltd have?
Inoviq Ltd has 138,775,670 shares outstanding.
What happened to Inoviq Ltd’s price movement after its last earnings report?
Inoviq Ltd reported an EPS of -AU$0.029 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Inoviq Ltd?
Currently, no hedge funds are holding shares in AU:IIQ
Inoviq Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:IIQ Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$60.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.83%
12-Months-Change
Fundamentals
Return on Equity
-37.78%
Trailing 12-Months
Asset Growth
-14.97%
Trailing 12-Months
Company Description
Inoviq Ltd
Inoviq Ltd (IIQ) is an Australian biotechnology company focused on developing innovative diagnostic solutions primarily in the fields of cancer and women's health. The company's core products include advanced diagnostic tests that leverage proprietary technology to detect various biomarkers associated with disease. Inoviq aims to improve patient outcomes through early detection and personalized treatment, operating within the healthcare sector, particularly in diagnostics and therapeutics.
Technical Analysis
BCAL Diagnostics Limited
―
Rhythm Biosciences Ltd.
―
Lumos Diagnostics Holdings Ltd.
―
Genetic Signatures Ltd.
―
Options Prices
Currently, No data available
---